查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1347914

表觀遺傳學市場：依產品、依方法、依應用、依最終用戶- 2030 年世界預測

Epigenetics Market by Offering (Kits, Reagents, Instruments, Software) Method (DNA Methylation, PCR, Chromatin Analysis, Histone, RNA Modification), Application (Oncology, Non-oncology) End User (Pharma, Academics, Hospitals) - Global Forecast to 2030
出版日期: | 出版商: Meticulous Research | 英文 208 Pages | 訂單完成後即時交付

價格

表觀遺傳學市場：依產品（試劑盒、試劑、儀器、軟體）、依方法（DNA 甲基化、PCR、染色質分析、組蛋白、RNA 修飾）、依應用（腫瘤學、非腫瘤學） 、依最終用戶（製藥、學術、醫院）- 2030 年世界預測

表觀遺傳學市場預計到 2030 年將達到 54.7 億美元，2023 年至 2030 年複合年增長率為 15.7%。

經過廣泛的二次和初步研究以及對市場情景的詳細分析，本報告研究了關鍵行業的驅動因素、限制因素、挑戰和機會。表觀遺傳學市場的成長是由於人口老化增加導致慢性病發病率上升、癌症盛行率增加、藥物研發成本上升以及藥物發現和治療中對錶觀遺傳學的關注。市場的發展，其背後的驅動力是研究的興起和基因組定序成本的下降。然而，缺乏熟練的專業人員正在限制這個市場的成長。

表觀遺傳學在非腫瘤疾病中的廣泛應用以及政府支持大規模基因組測序計畫的舉措預計將為該市場的利益相關者提供成長機會。然而，與表觀遺傳學程序相關的標準化問題以及表觀遺傳學在毒理學中的應用有限是市場成長的主要挑戰。

目錄

第 1 章 簡介

第二章研究方法論

  • 調查先決條件
  • 研究局限性

第三章執行摘要

第四章市場洞察

    市場
  • 概述
  • 影響市場成長的因素
    • 市場動態
    • 因子分析
  • 波特五力分析
  • 價格分析

第五章 表觀遺傳學市場評估（依產品分類）

  • 概述
  • 試劑盒和試劑
    • 試劑盒和檢測
    • 抗體
    • 蛋白質/酵素
    • 其他試劑
  • 服務
  • 軟件

第六章 表觀遺傳學市場評估（依方法）

  • 概述
  • DNA甲基化
    • 亞硫酸氫鹽轉化
    • 高解析度熔體 (HRM) 分析
    • 免疫沉澱
    • 其他 DNA 甲基化方法
  • 組蛋白修飾
  • RNA修飾
  • 聚合□鏈反應
  • 染色質分析
  • 超音波處理
  • 其他方法

第七章 表觀遺傳學市場評估（按應用）

  • 概述
  • 癌症領域
  • 非腫瘤學

第八章表觀遺傳學市場評估（由最終用戶）

  • 概述
  • 製藥和生物技術公司
  • 學術/研究機構
  • 醫院/診斷實驗室

第九章 表觀遺傳學市場評估（分地區）

  • 概述
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 意大利
    • 西班牙
    • 其他歐洲 (RoE)
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 其他亞太地區 (RoAPAC)
  • 拉丁美洲
  • 中東/非洲

第 10 章 競爭分析

  • 介紹
  • 主要成長策略
  • 競爭標桿
  • 比賽儀表板
    • 產業領導者
    • 市場差異化因素
    • 龍頭企業
    • 啟動
  • 市場份額分析（2022 年）
    • Merck KGaA（德國）
    • 10X Genomics, Inc.（美國）
    • Thermo Fisher Scientific（美國）
    • Illumina Inc.（美國）
    • QIAGEN N.V.（荷蘭）

第十一章 公司簡介（業務概況、財務概況、產品組合*SWOT分析、策略發展）

  • Merck KGaA
  • 10X Genomics, Inc.
  • Thermo Fisher Scientific Inc.
  • Illumina, Inc.
  • Qiagen N.V.
  • New England Biolabs
  • Epigentek Group Inc
  • Pacific Biosciences of California Inc.
  • Bio-Rad Laboratories, Inc.
  • PerkinElmer, Inc.
  • Active Motif
  • Zymo Research Corporation

（註：SWOT分析涵蓋5家主要公司）

第十二章附錄

Product Code: MRHC - 104945

The Epigenetics Market by Offering (Kits, Reagents, Instruments, Software) Method (DNA Methylation, PCR, Chromatin Analysis, Histone, RNA Modification), Application (Oncology, Non-oncology) End User (Pharma, Academics, Hospitals) - Global Forecast To 2030

The epigenetics market is expected to reach $5.47 billion by 2030, at a CAGR of 15.7% from 2023 to 2030.

Succeeding extensive secondary and primary research and in-depth analysis of the market scenario, the report studies the key industry drivers, restraints, challenges, and opportunities. The growth of the epigenetics market is driven by the rising incidence of chronic diseases due to growth in the aging population, the increasing prevalence of cancer, rising pharmaceutical R&D expenditures, the increasing focus on epigenetics in drug discovery & development, and the declining costs of genome sequencing. However, the lack of skilled professionals restrains the growth of this market.

The growing applications of epigenetics in non-oncology diseases and government initiatives supporting large-scale genomic sequencing projects are expected to generate growth opportunities for the stakeholders in this market. However, standardization concerns associated with epigenetics procedures and the limited applications of epigenetics in toxicology are major challenges to market growth.

Based on offering, the epigenetics market is segmented into kits & reagents, instruments and accessories, software and services. The kits & reagents segment is expected to grow at the fastest CAGR during the forecast period. The frequent and repetitive use of kits and reagents and the growing prevalence of chronic diseases are the major factors responsible for segment growth.

Based on method, the epigenetics market is segmented into DNA methylation, histone modification, RNA modification, polymerase chain reaction (PCR), chromatin analysis, sonication, and other methods. In 2023, the DNA methylation segment is expected to account for the largest share of the market. DNA methylation is an epigenetic mechanism that involves transferring a methyl group onto the C5 position of cytosine to form 5-methylcytosine. This process regulates gene expression by promoting or inhibiting the binding of transcription factors to DNA. Thus, it is useful in studying epigenetic changes in an organism. The increasing prevalence of cancer, technological advancements in PCR and sequencing, and the high focus on reducing costs associated with lengthy research and product approval processes support the segment's large share.

Based on application, the epigenetics market is segmented into oncology and non-oncology. In 2023, the oncology segment is expected to account for the largest share of the market. The large market share of this segment is attributed to the high burden of cancer, the high focus on R&D regarding cancer, and the growing demand for precision oncology.

Based on end user, the epigenetics market is segmented into pharmaceutical & biotechnology companies, academic & research institutes, and hospitals & diagnostic laboratories. In 2023, the pharmaceutical & biotechnology companies segment is expected to account for the largest share of the market. The segment's large share is attributed to the rising demand for research-related products, the increasing incidence of chronic diseases, pharmaceutical & biotechnology companies' rising R&D expenditures, technological advancements in epigenetics, and the introduction of new epigenetics products for chronic and rare diseases.

An in-depth analysis of the geographical scenario of the epigenetics market provides detailed qualitative and quantitative insights into five major geographies: North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa, along with the coverage of major countries in each region. Asia-Pacific is slated to register the highest CAGR during the forecast period. The market growth in this region is attributed to government initiatives for genetic diseases, growing cancer incidence, rising geriatric population, rapid rise in the prevalence of chronic diseases, rising R&D spending, and increasing healthcare expenditure.

Some of the key players operating in the global epigenetics market are Thermo Fisher Scientific Inc. (U.S.), Merck KGaA (Germany), Illumina, Inc. (U.S.), Qiagen N.V. (Netherlands), New England Biolabs (U.S.), Epigentek Group Inc. (U.S.), Pacific Biosciences of California Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), PerkinElmer, Inc. (U.S.), 10X Genomics, Inc. (U.S.), Active Motif (U.S.), and Zymo Research Corporation (U.S.).

Scope of the Report

Epigenetics Market Assessment, by Offering

  • Kits & Reagents
    • Kits & Assays
    • Antibodies
    • Proteins & Enzymes
    • Other Reagents

(Other reagents include buffers, controls, beads, histones, master mixes, and nuclease-free water)

  • Services
  • Software

Epigenetics Market Assessment, by Method

  • DNA Methylation
    • Bisulfite Conversion
    • High-resolution Melt (HRM) Analysis
    • Immunoprecipitation
    • Other DNA Methylation Methods

(Other DNA methylation methods include activity/inhibition assays, methylated DNA quantification, and methylated DNA amplification)

  • Histone Modification
  • RNA Modification
  • Polymerase Chain Reaction
  • Chromatin Analysis
  • Sonication
  • Other Methods

(Other methods include in vitro DNA-protein interactions, DNA demethylation, and miRNA analysis)

Epigenetics Market Assessment, by Application

  • Oncology
  • Non-oncology

Epigenetics Market Assessment, by End User

  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutes
  • Hospitals & Diagnostic Laboratories

Epigenetics Market Assessment, by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Rest of Asia-Pacific
  • Latin America
  • Middle East & Africa

TABLE OF CONTENTS

1. Introduction

  • 1.1. Market Definition & Scope
  • 1.2. Market Ecosystem
  • 1.3. Currency
  • 1.4. Key Stakeholders

2. Research Methodology

  • 2.1. Research Process
  • 2.2. Data Collection & Validation
    • 2.2.1. Secondary Research
    • 2.2.2. Primary Research
  • 2.3. Market Assessment
    • 2.3.1. Market Size Estimation
      • 2.3.1.1. Bottom-up Approach
      • 2.3.1.2. Top-down Approach
      • 2.3.1.3. Growth Forecast
    • 2.3.2. Market Share Analysis
  • 2.4. Assumptions for the Study
  • 2.5. Limitations for the Study

3. Executive Summary

4. Market Insights

  • 4.1. Overview
  • 4.2. Factors Affecting Market Growth
    • 4.2.1. Market Dynamics
    • 4.2.2. Factor Analysis
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Buyers
    • 4.3.2. Bargaining Power of Suppliers
    • 4.3.3. Threat of Substitutes
    • 4.3.4. Threat of New Entrants
    • 4.3.5. Degree of Competition
  • 4.4. Pricing Analysis

5. Epigenetics Market Assessment, by Offering

  • 5.1. Overview
  • 5.2. Kits & Reagents
    • 5.2.1. Kits & Assays
    • 5.2.2. Antibodies
    • 5.2.3. Proteins & Enzymes
    • 5.2.4. Other Reagents
  • 5.3. Services
  • 5.4. Software

6. Epigenetics Market Assessment, by Method

  • 6.1. Overview
  • 6.2. DNA Methylation
    • 6.2.1. Bisulfite Conversion
    • 6.2.2. High-resolution Melt (HRM) Analysis
    • 6.2.3. Immunoprecipitation
    • 6.2.4. Other DNA Methylation Methods
  • 6.3. Histone Modification
  • 6.4. RNA Modification
  • 6.5. Polymerase Chain Reaction
  • 6.6. Chromatin Analysis
  • 6.7. Sonication
  • 6.8. Other Methods

7. Epigenetics Market Assessment, by Application

  • 7.1. Overview
  • 7.2. Oncology
  • 7.3. Non-oncology

8. Epigenetics Market Assessment, by End User

  • 8.1. Overview
  • 8.2. Pharmaceutical & Biotechnology Companies
  • 8.3. Academic & Research Institutes
  • 8.4. Hospitals & Diagnostic Laboratories

9. Epigenetics Market Assessment, by Geography

  • 9.1. Overview
  • 9.2. North America
    • 9.2.1. U.S.
    • 9.2.2. Canada
  • 9.3. Europe
    • 9.3.1. Germany
    • 9.3.2. France
    • 9.3.3. U.K.
    • 9.3.4. Italy
    • 9.3.5. Spain
    • 9.3.6. Rest of Europe (RoE)
  • 9.4. Asia-Pacific
    • 9.4.1. Japan
    • 9.4.2. China
    • 9.4.3. India
    • 9.4.4. Rest of Asia-Pacific (RoAPAC)
  • 9.5. Latin America
  • 9.6. Middle East & Africa

10. Competitive Analysis

  • 10.1. Introduction
  • 10.2. Key Growth Strategies
  • 10.3. Competitive Benchmarking
  • 10.4. Competitive Dashboard
    • 10.4.1. Industry Leaders
    • 10.4.2. Market Differentiators
    • 10.4.3. Vanguards
    • 10.4.4. Emerging Companies
  • 10.5. Market Share Analysis (2022)
    • 10.5.1. Merck KGaA (Germany)
    • 10.5.2. 10X Genomics, Inc. (U.S.)
    • 10.5.3. Thermo Fisher Scientific Inc. (U.S.)
    • 10.5.4. Illumina, Inc. (U.S.)
    • 10.5.5. QIAGEN N.V. (Netherlands)

11. Company Profiles (Business Overview, Financial Overview, Product Portfolio *SWOT Analysis, and Strategic Developments)

  • 11.1. Merck KGaA
  • 11.2. 10X Genomics, Inc.
  • 11.3. Thermo Fisher Scientific Inc.
  • 11.4. Illumina, Inc.
  • 11.5. Qiagen N.V.
  • 11.6. New England Biolabs
  • 11.7. Epigentek Group Inc
  • 11.8. Pacific Biosciences of California Inc.
  • 11.9. Bio-Rad Laboratories, Inc.
  • 11.10. PerkinElmer, Inc.
  • 11.11. Active Motif
  • 11.12. Zymo Research Corporation

(Note: SWOT Analysis Provided is for Top 5 Players in the Market)

12. Appendix

  • 12.1. Questionnaire
  • 12.2. Available Customization
  • Table 1 Healthcare Expenditure as A Percentage Of GDP, by Country, 2020 Vs. 2021
  • Table 2 Number of New Cancer Cases, by Type, 2020 Vs. 2030
  • Table 3 Incidence of Common Genetic Disorders, 2021
  • Table 4 Pricing: Epigenetics Antibodies
  • Table 5 Pricing of Epigenetics Antibodies Based on Method
  • Table 6 Prices of Epigenetics Kits
  • Table 7 Global Epigenetics Market, by Offering, 2021-2030 (USD Million)
  • Table 8 Global Epigenetics Kits & Reagents Market, by Product, 2021-2030 (USD Million)
  • Table 9 Global Epigenetics Kits & Reagents Market, by Country/Region, 2021-2030 (USD Million)
  • Table 10 Key Companies Offering Epigenetics Kits & Assays
  • Table 11 Global Epigenetics Kits & Assays Market, by Country/Region, 2021-2030 (USD Million)
  • Table 12 Key Companies Offering Epigenetics Antibodies
  • Table 13 Global Epigenetics Antibodies Market, by Country/Region, 2021-2030 (USD Million)
  • Table 14 Key Companies Offering Epigenetics Proteins & Enzymes
  • Table 15 Global Epigenetics Proteins & Enzymes Market, by Country/Region, 2021-2030 (USD Million)
  • Table 16 Key Companies Offering Other Epigenetics Reagents
  • Table 17 Global Other Epigenetics Reagents Market, by Country/Region, 2021-2030 (USD Million)
  • Table 18 Key Companies Offering Epigenetics Instruments & Accessories
  • Table 19 Global Epigenetics Instruments & Accessories Market, by Country/Region, 2021-2030 (USD Million)
  • Table 20 Global Epigenetics Services Market, by Country/Region, 2021-2030 (USD Million)
  • Table 21 Key Companies Offering Epigenetics Software
  • Table 22 Global Epigenetics Software Market, by Country/Region, 2021-2030 (USD Million)
  • Table 23 Global Epigenetics Market, by Method, 2021-2030 (USD Million)
  • Table 24 Global Epigenetics Market for DNA Methylation, by Type, 2021-2030 (USD Million)
  • Table 25 Global Epigenetics Market for DNA Methylation, by Country/Region, 2021-2030 (USD Million)
  • Table 26 Global Epigenetics Market for Bisulfite Conversion, by Country/Region, 2021-2030 (USD Million)
  • Table 27 Global Epigenetics Market for High-Resolution Melt (HRM)Analysis, by Country/Region, 2021-2030 (USD Million)
  • Table 28 Global Epigenetics Market for Immunoprecipitation, by Country/Region, 2021-2030 (USD Million)
  • Table 29 Global Epigenetics Market for Other DNA Methylation Methods, by Country/Region, 2021-2030 (USD Million)
  • Table 30 Global Epigenetics Market for Histone Modification, by Country/Region, 2021-2030 (USD Million)
  • Table 31 Global Epigenetics Market for RNA Modifications, by Country/Region, 2021-2030 (USD Million)
  • Table 32 Global Epigenetics Market for Polymerase Chain Reaction (PCR), by Country/Region, 2021-2030 (USD Million)
  • Table 33 Global Epigenetics Market for Chromatin Analysis, by Country/Region, 2021-2030 (USD Million)
  • Table 34 Global Epigenetics Market for Sonication, by Country/Region, 2021-2030 (USD Million)
  • Table 35 Global Epigenetics Market for Other Methods, by Country/Region, 2021-2030 (USD Million)
  • Table 36 Global Epigenetics Market, by Application, 2021-2030 (USD Million)
  • Table 37 Estimated Number of New Cancer Cases, by Type, 2020 Vs. 2030
  • Table 38 Global Epigenetics Market for Oncology, by Country/Region, 2021-2030 (USD Million)
  • Table 39 Global Epigenetics Market for Non-Oncology, by Country/Region, 2021-2030 (USD Million)
  • Table 40 Global Epigenetics Market, by End User, 2021-2030 (USD Million)
  • Table 41 Global Epigenetics Market for Pharmaceutical & Biotechnology Companies, by Country/Region, 2021-2030 (USD Million)
  • Table 42 National Institutes of Health Funding, 2020-2024 (USD Million)
  • Table 43 Global Epigenetics Market for Academic & Research Institutes, by Country/Region, 2021-2030 (USD Million)
  • Table 44 Global Epigenetics Market for Hospitals & Diagnostic Laboratories, by Country/Region, 2021-2030 (USD Million)
  • Table 45 Global Epigenetics Market, by Country/Region, 2021-2030 (USD Million)
  • Table 46 North America: Epigenetics Market, by Country, 2021-2030 (USD Million)
  • Table 47 North America: Epigenetics Market, by Offering, 2021-2030 (USD Million)
  • Table 48 North America: Epigenetics Kits and Reagents Market, by Product, 2021-2030 (USD Million)
  • Table 49 North America: Epigenetics Market, by Method, 2021-2030 (USD Million)
  • Table 50 North America: Epigenetics Market for DNA Methylation, by Type, 2021-2030 (USD Million)
  • Table 51 North America: Epigenetics Market, by Application, 2021-2030 (USD Million)
  • Table 52 North America: Epigenetics Market, by End User, 2021-2030 (USD Million)
  • Table 53 U.S. Number of New Cancer Cases, 2021 Vs. 2022
  • Table 54 U.S.: Epigenetics Market, by Offering, 2021-2030 (USD Million)
  • Table 55 U.S.: Epigenetics Kits and Reagents Market, by Product, 2021-2030 (USD Million)
  • Table 56 U.S.: Epigenetics Market, by Method, 2021-2030 (USD Million)
  • Table 57 U.S.: Epigenetics Market for DNA Methylation, by Type, 2021-2030 (USD Million)
  • Table 58 U.S.: Epigenetics Market, by Application, 2021-2030 (USD Million)
  • Table 59 U.S.: Epigenetics Market, by End User, 2021-2030 (USD Million)
  • Table 60 Canada: Epigenetics Market, by Offering, 2021-2030 (USD Million)
  • Table 61 Canada: Epigenetics Kits and Reagents Market, by Product, 2021-2030 (USD Million)
  • Table 62 Canada: Epigenetics Market, by Method, 2021-2030 (USD Million)
  • Table 63 Canada: Epigenetics Market for DNA Methylation, by Type, 2021-2030 (USD Million)
  • Table 64 Canada: Epigenetics Market, by Application, 2021-2030 (USD Million)
  • Table 65 Canada: Epigenetics Market, by End User, 2021-2030 (USD Million)
  • Table 66 Europe: Epigenetics Market, by Country/Region, 2021-2030 (USD Million)
  • Table 67 Europe: Epigenetics Market, by Offering, 2021-2030 (USD Million)
  • Table 68 Europe: Epigenetics Kits and Reagents Market, by Product, 2021-2030 (USD Million)
  • Table 69 Europe: Epigenetics Market, by Method, 2021-2030 (USD Million)
  • Table 70 Europe: Epigenetics Market for DNA Methylation, by Type, 2021-2030 (USD Million)
  • Table 71 Europe: Epigenetics Market, by Application, 2021-2030 (USD Million)
  • Table 72 Europe: Epigenetics Market, by End User, 2021-2030 (USD Million)
  • Table 73 Germany: Epigenetics Market, by Offering, 2021-2030 (USD Million)
  • Table 74 Germany: Epigenetics Kits and Reagents Market, by Product, 2021-2030 (USD Million)
  • Table 75 Germany: Epigenetics Market, by Method, 2021-2030 (USD Million)
  • Table 76 Germany: Epigenetics Market for DNA Methylation, by Type, 2021-2030 (USD Million)
  • Table 77 Germany: Epigenetics Market, by Application, 2021-2030 (USD Million)
  • Table 78 Germany: Epigenetics Market, by End User, 2021-2030 (USD Million)
  • Table 79 France: Epigenetics Market, by Offering, 2021-2030 (USD Million)
  • Table 80 France: Epigenetics Kits and Reagents Market, by Product, 2021-2030 (USD Million)
  • Table 81 France: Epigenetics Market, by Method, 2021-2030 (USD Million)
  • Table 82 France: Epigenetics Market for DNA Methylation, by Type, 2021-2030 (USD Million)
  • Table 83 France: Epigenetics Market, by Application, 2021-2030 (USD Million)
  • Table 84 France: Epigenetics Market, by End User, 2021-2030 (USD Million)
  • Table 85 Italy: Epigenetics Market, by Offering, 2021-2030 (USD Million)
  • Table 86 Italy: Epigenetics Kits and Reagents Market, by Product, 2021-2030 (USD Million)
  • Table 87 Italy: Epigenetics Market, by Method, 2021-2030 (USD Million)
  • Table 88 Italy: Epigenetics Market for DNA Methylation, by Type, 2021-2030 (USD Million)
  • Table 89 Italy: Epigenetics Market, by Application, 2021-2030 (USD Million)
  • Table 90 Italy: Epigenetics Market, by End User, 2021-2030 (USD Million)
  • Table 91 U.K.: Epigenetics Market, by Offering, 2021-2030 (USD Million)
  • Table 92 U.K.: Epigenetics Kits and Reagents Market, by Product, 2021-2030 (USD Million)
  • Table 93 U.K.: Epigenetics Market, by Method, 2021-2030 (USD Million)
  • Table 94 U.K.: Epigenetics Market for DNA Methylation, by Type, 2021-2030 (USD Million)
  • Table 95 U.K.: Epigenetics Market, by Application, 2021-2030 (USD Million)
  • Table 96 U.K.: Epigenetics Market, by End User, 2021-2030 (USD Million)
  • Table 97 Spain: Epigenetics Market, by Offering, 2021-2030 (USD Million)
  • Table 98 Spain: Epigenetics Kits and Reagents Market, by Product, 2021-2030 (USD Million)
  • Table 99 Spain: Epigenetics Market, by Method, 2021-2030 (USD Million)
  • Table 100 Spain: Epigenetics Market for DNA Methylation, by Type, 2021-2030 (USD Million)
  • Table 101 Spain: Epigenetics Market, by Application, 2021-2030 (USD Million)
  • Table 102 Spain: Epigenetics Market, by End User, 2021-2030 (USD Million)
  • Table 103 Estimated Number of New Cancer Cases, by Country, 2020 Vs. 2030
  • Table 104 Rest of Europe: Epigenetics Market, by Offering, 2021-2030 (USD Million)
  • Table 105 Rest of Europe: Epigenetics Kits and Reagents Market, by Product, 2021-2030 (USD Million)
  • Table 106 Rest of Europe: Epigenetics Market, by Method, 2021-2030 (USD Million)
  • Table 107 Rest of Europe: Epigenetics Market for DNA Methylation, by Type, 2021-2030 (USD Million)
  • Table 108 Rest of Europe: Epigenetics Market, by Application, 2021-2030 (USD Million)
  • Table 109 Rest of Europe: Epigenetics Market, by End User, 2021-2030 (USD Million)
  • Table 110 Asia-Pacific: Epigenetics Market, by Country/Region, 2021-2030 (USD Million)
  • Table 111 Asia-Pacific: Epigenetics Market, by Offering, 2021-2030 (USD Million)
  • Table 112 Asia-Pacific: Epigenetics Kits and Reagents Market, by Product, 2021-2030 (USD Million)
  • Table 113 Asia-Pacific: Epigenetics Market, by Method, 2021-2030 (USD Million)
  • Table 114 Asia-Pacific: Epigenetics Market for DNA Methylation, by Type, 2021-2030 (USD Million)
  • Table 115 Asia-Pacific: Epigenetics Market, by Application, 2021-2030 (USD Million)
  • Table 116 Asia-Pacific: Epigenetics Market, by End User, 2021-2030 (USD Million)
  • Table 117 China: Epigenetics Market, by Offering, 2021-2030 (USD Million)
  • Table 118 China: Epigenetics Kits and Reagents Market, by Product, 2021-2030 (USD Million)
  • Table 119 China: Epigenetics Market, by Method, 2021-2030 (USD Million)
  • Table 120 China: Epigenetics Market for DNA Methylation, by Type, 2021-2030 (USD Million)
  • Table 121 China: Epigenetics Market, by Application, 2021-2030 (USD Million)
  • Table 122 China: Epigenetics Market, by End User, 2021-2030 (USD Million)
  • Table 123 Japan: Epigenetics Market, by Offering, 2021-2030 (USD Million)
  • Table 124 Japan: Epigenetics Kits and Reagents Market, by Product, 2021-2030 (USD Million)
  • Table 125 Japan: Epigenetics Market, by Method, 2021-2030 (USD Million)
  • Table 126 Japan: Epigenetics Market for DNA Methylation, by Type, 2021-2030 (USD Million)
  • Table 127 Japan: Epigenetics Market, by Application, 2021-2030 (USD Million)
  • Table 128 Japan: Epigenetics Market, by End User, 2021-2030 (USD Million)
  • Table 129 India: Epigenetics Market, by Offering, 2021-2030 (USD Million)
  • Table 130 India: Epigenetics Kits and Reagents Market, by Product, 2021-2030 (USD Million)
  • Table 131 India: Epigenetics Market, by Method, 2021-2030 (USD Million)
  • Table 132 India: Epigenetics Market for DNA Methylation, by Type, 2021-2030 (USD Million)
  • Table 133 India: Epigenetics Market, by Application, 2021-2030 (USD Million)
  • Table 134 India: Epigenetics Market, by End User, 2021-2030 (USD Million)
  • Table 135 Estimated Number of New Cancer Cases, by Country, 2020 Vs. 2030
  • Table 136 Rest of Asia-Pacific: Epigenetics Market, by Offering, 2021-2030 (USD Million)
  • Table 137 Rest of Asia-Pacific: Epigenetics Kits and Reagents Market, by Product, 2021-2030 (USD Million)
  • Table 138 Rest of Asia-Pacific: Epigenetics Market, by Method, 2021-2030 (USD Million)
  • Table 139 Rest of Asia-Pacific: Epigenetics Market for DNA Methylation, by Type, 2021-2030 (USD Million)
  • Table 140 Rest of Asia-Pacific: Epigenetics Market, by Application, 2021-2030 (USD Million)
  • Table 141 Rest of Asia-Pacific: Epigenetics Market, by End User, 2021-2030 (USD Million)
  • Table 142 Latin America and The Caribbean: New Cancer Cases, 2020 Vs. 2040
  • Table 143 Latin America and The Caribbean: Percentage of Older Population (65 Years and Above)
  • Table 144 Latin America: Epigenetics Market, by Offering, 2021-2030 (USD Million)
  • Table 145 Latin America: Epigenetics Kits and Reagents Market, by Product, 2021-2030 (USD Million)
  • Table 146 Latin America: Epigenetics Market, by Method, 2021-2030 (USD Million)
  • Table 147 Latin America: Epigenetics Market for DNA Methylation, by Type, 2021-2030 (USD Million)
  • Table 148 Latin America: Epigenetics Market, by Application, 2021-2030 (USD Million)
  • Table 149 Latin America: Epigenetics Market, by End User, 2021-2030 (USD Million)
  • Table 150 Middle East & Africa: Percentage of Older Population (65 Years and Above)
  • Table 151 Africa: Number of New Cancer Cases, 2020 Vs. 2040
  • Table 152 Middle East & Africa: Epigenetics Market, by Offering, 2021-2030 (USD Million)
  • Table 153 Middle East & Africa: Epigenetics Kits and Reagents Market, by Product, 2021-2030 (USD Million)
  • Table 154 Middle East & Africa: Epigenetics Market, by Method, 2021-2030 (USD Million)
  • Table 155 Middle East & Africa: Epigenetics Market for DNA Methylation, by Type, 2021-2030 (USD Million)
  • Table 156 Middle East & Africa: Epigenetics Market, by Application, 2021-2030 (USD Million)
  • Table 157 Middle East & Africa: Epigenetics Market, by End User, 2021-2030 (USD Million)
  • Table 158 Recent Developments, by Company, 2020-2023